Erenumab
Indication
Prophylaxis of migraine (in patients who have at least 4 migraine days per month)
Grey
Brand:
Aimovig®
Nice TA:
Commissioning responsibility:
PbR excluded:
No
BNF chapter:
Central nervous system
Background
Recommendation
LSCMMG Recommendation:
Grey
Reason for decision:
Prioritised for review
Supporting documents: